[Debrisoquin as a part of combined antihypertensive therapy].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001581:Benzothiadiazines; D003647:Debrisoquin / Q000627:therapeutic use*; D004232:Diuretics; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007546:Isoquinolines / Q000627:therapeutic use*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D001581:Benzothiadiazines; D004232:Diuretics; D007546:Isoquinolines; D049993:Sodium Chloride Symporter Inhibitors; D008750:Methyldopa; D003647:Debrisoquin
Debrisokin som led i kombineret antihypertensiv terapi